Category: Research & Development
Research & Development market research reports by Global Market Insights
-
Metabolic Disorder Therapeutics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Metabolic Disorder Therapeutics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 Metabolic Disorder Therapeutics Market size will record 7.5% CAGR between 2024 and 2032, led by significant investments in R&D by pharmaceutical and biotechnology companies to foster ... Read More
-
Organoids and Spheroids Market
Organoids and Spheroids Market Global Organoids And Spheroids Market was valued at USD 1.1 billion in 2023 growing at a CAGR of 19.1% between 2024 and 2032, due to advancements in biotechnology, particularly in 3D cell culture and bioengineering, coupled with the rising demand for personalized medic ... Read More
-
Healthcare Regulatory Affairs Outsourcing Market Size - By Services, By Indication, By Product Stage (Preclinical, Clinical, PMA), By End-use (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies) & Global Forecast, 2024 - 2032
Healthcare Regulatory Affairs Outsourcing Market Size - By Services, By Indication, By Product Stage (Preclinical, Clinical, PMA), By End-use (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies) & Global Forecast, 2024 - 2032 Healthcare Regulatory Affairs Outsourcing Market ... Read More
-
Mice Model Market - By Mice (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application, By Use, By End-use & Forecast, 2023 - 2032
Mice Model Market - By Mice (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application, By Use, By End-use & Forecast, 2023 - 2032 Global Mice Model Market is poised to depict significant growth from 2023 to 2032 owing ... Read More
-
eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, Pharma/Biotech Companies, Hospitals & Clinics), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Deli ... Read More
-
Biosimilars Market Size By Product (Recombinant Non-Glycosylated Proteins {Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Interferon}, Recombinant Glycosylated Proteins {Erythropoietin, Monoclonal Antibodies, Follitropin, Low Molecular Weight Heparin}), By Application (Hematology {Neutropenia, Anemia}, Oncology {Lung Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA Technology, Monoclonal Antibodies Technology) Industry Analysis Report, Regional Outlook, Application Potential, COVID-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2030
Biosimilars Market Size By Product (Recombinant Non-Glycosylated Proteins {Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Interferon}, Recombinant Glycosylated Proteins {Erythropoietin, Monoclonal Antibodies, Follitropin, Low Molecular Weight Heparin}), By Application (Hematol ... Read More
-
eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, Pharma/Biotech Companies, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Deli ... Read More
-
Chromatography Software Market Size By Device Type (Standalone, Integrated), By Deployment Mode (On-premise, Web-based, Cloud-based), By Application (Pharmaceutical Industry, Environmental Testing, Forensic Testing, Food & Beverage Industry), By End-use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Testing Facilities, Hospitals/Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028
Chromatography Software Market Size By Device Type (Standalone, Integrated), By Deployment Mode (On-premise, Web-based, Cloud-based), By Application (Pharmaceutical Industry, Environmental Testing, Forensic Testing, Food & Beverage Industry), By End-use (Pharmaceutical and Biotechnology Companies, A ... Read More